Is the RSV Vaccine Covered by the VICP?

RSV vaccines are newer options for older adults and, in some cases, for pregnant people. When someone has a serious problem after an RSV shot, a natural next question is whether the National Vaccine Injury Compensation Program (VICP) applies.

According to the Health Resources and Services Administration (HRSA) covered-vaccines page (date last reviewed: September 2026), RSV vaccines are not listed among VICP-covered vaccine categories.

That answer matters because the VICP only covers vaccine categories that meet specific federal requirements and appear on HRSA’s covered list. This article explains that rule in plain English, how new categories get added, how that compares with another common “not covered” example (shingles), what official CICP materials currently say about PREP Act declarations, and what practical steps often help if you believe you were seriously hurt. It is educational information, not medical or legal advice.

What HRSA’s covered list includes — and does not

HRSA’s National Vaccine Injury Compensation Program covers most vaccines routinely given in the United States. For a vaccine category to be covered, HRSA states that the Centers for Disease Control and Prevention (CDC) must recommend the category for routine administration to children or pregnant women, and it must be subject to an excise tax by federal law. The category must also be added to the VICP by the Secretary of Health and Human Services.

HRSA’s public covered-vaccines page lists categories such as diphtheria, Hib, hepatitis A and B, HPV, seasonal influenza, measles, mumps, meningococcal, pertussis, pneumococcal conjugate, polio, rotavirus, rubella, tetanus, and varicella (chickenpox). RSV does not appear on that list.

HRSA also notes explicitly that herpes zoster (shingles) vaccine is not a VICP-covered vaccine. RSV sits in a similar place from a coverage standpoint: it is a licensed, recommended product for certain groups, but it is not currently on the VICP covered-vaccines list.

So if the only shot in question is an RSV vaccine, a VICP petition is generally not the federal path described for covered vaccines. This is a coverage rule about which categories the program includes. It is not a statement that RSV vaccines never cause problems, or that every reaction after an RSV shot is unrelated to vaccination. Coverage and medical causation are different questions.

RSV products people usually mean

For everyday context only (not a recommendation and not a side-effect catalog), CDC materials describe several FDA-licensed RSV vaccines used in the United States, including:

• Abrysvo (Pfizer)
• Arexvy (GSK)
• mResvia (Moderna)

CDC recommends RSV vaccination for certain adults (including all adults ages 75 and older, and adults ages 50–74 at increased risk of severe RSV). CDC also recommends a single dose of maternal Abrysvo for pregnant people at 32 through 36 weeks’ gestation during seasonal windows, to help protect infants. Arexvy and mResvia are not approved for use during pregnancy.

Separately, CDC discusses RSV monoclonal antibodies given to infants (for example, products used after birth). Those are antibody immunizations, not the adult/maternal RSV vaccines named above. Program coverage questions still turn on official VICP and CICP materials for the specific product involved — not on brand familiarity alone.

Product names on a vaccination record matter. If you are unsure which product you received, ask the clinic or pharmacy for the vaccine name and, if available, the lot number.

How a new vaccine category gets into the VICP

HRSA’s FAQ explains that coverage depends on whether the vaccine falls within a category already covered:

• If a new product is in a category already covered (for example, a new hepatitis B vaccine), it is generally already covered under that category.
• If the product is in a category not covered (HRSA’s example is yellow fever), it is not covered until the general category becomes covered.

For a category of vaccines to be covered, HRSA states that the category must be:

1. Recommended by the CDC for routine administration to children or pregnant women,
2. Subject to a federal excise tax, and
3. Added to the VICP by the Secretary of Health and Human Services.

Maternal Abrysvo is recommended by CDC for routine use in pregnancy. That is one of the three conditions HRSA describes — but recommendation alone is not enough. Until a category meets the full set of requirements and appears on HRSA’s covered list, it is not a VICP-covered vaccine. As of the September 2026 review of HRSA’s covered-vaccines page, RSV is still not listed.

Coverage rules can change over time if federal requirements are met and the Secretary adds a category. Anyone checking eligibility should look at the current HRSA covered-vaccines page rather than assuming yesterday’s list still applies.

What about the CICP?

The Countermeasures Injury Compensation Program (CICP) is a different federal program from the VICP. It covers certain “countermeasures” identified in declarations under the Public Readiness and Emergency Preparedness Act (PREP Act) — products used against declared public health emergencies or security threats.

HRSA’s CICP covered-countermeasures page (date last reviewed: June 2026) lists PREP Act declarations for medical countermeasures against:

• Acute Radiation Syndrome
• Anthrax
• Botulinum toxin
• COVID-19
• Ebola
• Hantavirus
• Marburg
• Nerve agents and certain insecticides
• Pandemic influenza
• Smallpox and other orthopoxviruses (for example, mpox)
• Zika

RSV is not among those listed declarations. On the materials HRSA publishes for the public, RSV vaccines are therefore not shown as CICP-covered countermeasures the way COVID-19 vaccines are.

Be precise about what that means: official pages do not currently put routine RSV vaccines (Abrysvo, Arexvy, mResvia) on the VICP covered list or on the CICP PREP Act declaration list HRSA summarizes. If a declaration or coverage rule changed after those review dates, the live HRSA pages would be the place to confirm. This article does not invent a pathway that those pages do not describe.

COVID-19 vaccines remain the common example of products handled under the CICP rather than the VICP. That contrast is useful — and it does not, by itself, place RSV into the CICP.

What this means if you were seriously hurt after an RSV shot

If your only vaccination at issue is an RSV vaccine, do not assume a VICP petition is available. HRSA’s covered-vaccine list is the starting point. Based on current public HRSA materials, do not assume a CICP claim is available either.

That does not mean you have no options, and it does not mean you should ignore symptoms. It means the pathway may be different from the federal no-fault petition process many vaccine-injury articles describe for covered shots.

A few practical points:

• Get medical care first. Serious or worsening symptoms deserve prompt evaluation. Tell clinicians what vaccine you received and when symptoms began, and ask that the timeline be recorded clearly.
• Keep the vaccination record. Product name, date, location, and lot number (if available) help sort out which program — if any — might apply, and help a lawyer review the facts accurately.
• Do not mix up programs. The VICP covers listed routine vaccine categories. The CICP covers certain PREP Act countermeasures such as COVID-19 vaccines. RSV vaccines are not on HRSA’s VICP covered list; they also do not appear on HRSA’s summary list of CICP PREP Act declaration categories.
• If more than one shot was given. Write down each product and date. Coverage can differ shot by shot. For example, a seasonal flu vaccine is generally VICP-covered, while an RSV vaccine given the same day is not on the VICP list. HRSA notes in other contexts that when both a VICP-covered vaccine and a CICP-covered countermeasure are involved, a person may be able to explore either program or both, depending on the facts — but that still depends on which products were actually given.
• Talk with someone who knows this area. Vaccine injury and product-liability questions are specialized. A conversation with a lawyer who handles these cases can help you understand what does and does not fit — without you having to decode federal coverage charts alone.

Soft checklist if you are sorting this out

1. Confirm the exact vaccine name on your record (Abrysvo, Arexvy, mResvia, or another product).
2. Note the date of vaccination and when symptoms first appeared.
3. Gather related medical records and a simple symptom timeline.
4. Ask a clinician about ongoing care needs.
5. If the injury was serious or lasting, consider talking with counsel familiar with vaccine-related claims so you can learn whether any compensation pathway fits your facts.

Deadlines matter in federal programs that do apply. For VICP injury petitions involving covered vaccines, HRSA materials state that petitions generally must be filed within three years after the first symptom or significant aggravation of the injury. Death claims follow different timing rules. For the CICP, HRSA states that a Request for Benefits generally must be filed within one year of receiving or using the countermeasure. Those clocks are not a substitute for advice about an RSV-only case; they are a reminder that waiting can close doors when a covered product is involved.

Reporting a reaction to VAERS (the Vaccine Adverse Event Reporting System) can help public health monitoring. It does not start a VICP or CICP claim, and it does not stop filing clocks on programs that apply.

A calm next step

No — according to HRSA’s covered-vaccines list as reviewed in September 2026, RSV vaccines are not covered by the VICP. HRSA’s public CICP materials also do not list RSV among current PREP Act declaration categories. Shingles vaccines are another well-known example of products HRSA states are outside the VICP. If you believe you were seriously injured after an RSV shot, focus on medical care, accurate records, and getting case-specific guidance rather than assuming either federal no-fault program automatically applies.

VaccineInjuries.org is not a law firm and does not represent clients. The site exists to help people understand these programs in plain English and, when appropriate, connect with lawyers who handle vaccine injury cases.

If you want to talk with an independent attorney about whether your situation may fit any available path, you can submit your information for free on VaccineInjuries.org. There is no obligation to move forward before you are ready.

Disclaimer

This article is for informational purposes only and is not legal or medical advice. Vaccine injury claims involve specific rules, programs, and deadlines that depend on the facts of each case. Reading this page does not create an attorney-client relationship. For advice about your situation, speak with a qualified attorney. For medical concerns, contact a licensed clinician or emergency services.